2020
DOI: 10.1016/j.ijnurstu.2019.103504
|View full text |Cite
|
Sign up to set email alerts
|

The RESPECT trial–Replacement of peripheral intravenous catheters according to clinical reasons or every 96 hours: A randomized, controlled, non-inferiority trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
18
1
9

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(35 citation statements)
references
References 29 publications
7
18
1
9
Order By: Relevance
“…Research within vascular access has focused on the reduction of infection; however, the scale and implications of PIVC failure have only recently been acknowledged. This trial is one of the few recently published studies addressing the maintenance phase of the PIVC [20,29,30]. It has provided important information on the effectiveness of post-insertion PIVC maintenance, specifically, optimising patency through flushing.…”
Section: Discussionmentioning
confidence: 99%
“…Research within vascular access has focused on the reduction of infection; however, the scale and implications of PIVC failure have only recently been acknowledged. This trial is one of the few recently published studies addressing the maintenance phase of the PIVC [20,29,30]. It has provided important information on the effectiveness of post-insertion PIVC maintenance, specifically, optimising patency through flushing.…”
Section: Discussionmentioning
confidence: 99%
“…[7] Similarly, there was no difference in phlebitis or catheter-related bloodstream infection between the 2 removal approaches. [6] Additional large RCTs from China and Brazil had consistent findings [8,9] and a global observational study of over 40,000 PIVCs found PIVC dwell was not associated with phlebitis. [10]…”
Section: Introductionmentioning
confidence: 83%
“…Another may have been reluctance to generalize results of Australian trials to other health systems, although recent confirmatory trials have been undertaken elsewhere. [8,9] Finally, no published framework exists to guide implementation of clinically indicated removal policy, suggesting hospitals need guidance to overcome the barriers to change that exist at the patient, clinician, organizational, and outer regulatory body level. [15] Implementation using the CFIR framework…”
Section: Implementation Into Practicementioning
confidence: 99%
“…Trata-se de um estudo caracterizado como análise post hoc de um ensaio clínico randômico controlado (ECRC) de não inferioridade sobre a influência do modo de retirada do CIP na ocorrência de flebite, denominado "Remoção de cateteres intravenosos periféricos a cada 96 horas ou segundo indicação clínica: estudo clínico, randômico e de não inferioridade" e representado pelo acrônimo ResPeCt advindo do título do estudo na língua inglesa (Removal of Peripheral Intravenous Catheters according to clinical signs or every 96 hours: A randomized, controlled and non-inferiority study) (15) . O Estudo ResPeCt, um estudo clínico, randômico, controlado e de não inferioridade, teve como objetivo verificar se a remoção do CIP mediante indicação clínica não era inferior à remoção programada a cada 96 horas quanto à ocorrência de flebite e comparar a gravidade da flebite, tempo de permanência do CIP e outras complicações de terapia intravenosa entre os grupos de estudo.…”
Section: Desenho Do Estudounclassified
“…A taxa de incidência de flebite/1000 CIP-dia foi 14,9 no grupo indicação clínica e 23,8 no grupo remoção a cada 96 horas (p = 0,006). O estudo evidenciou que a retirada segundo indicação clínica não foi inferior à retirada a cada 96 horas quanto à ocorrência de flebite (15) . O estudo primário foi incluído em revisão sistemática Cochrane sobre ocorrência de flebite associada a cateteres intravenosos periféricos, sendo considerado robusto para sustentar tal revisão (14) .…”
Section: Desenho Do Estudounclassified